US Representative

H. Griffith 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 5)

Legislative Session

Primary Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4458

Introduced
7/3/23  
Refer
7/3/23  
Improving Contract Transparency for the SNS Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4459

Introduced
7/3/23  
Refer
7/3/23  
Improving Contract Transparency at BARDA Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4460

Introduced
7/3/23  
Refer
7/3/23  
NO VOTE for Non-Citizens Act of 2023 Non-citizens: Outlawed from Voting in Our Trusted Elections Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4513

Introduced
7/10/23  
Commerce Spectrum Coordination Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB467

Introduced
1/24/23  
Refer
1/24/23  
Refer
1/24/23  
Report Pass
3/24/23  
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB5393

Introduced
9/12/23  
Refer
9/12/23  
Refer
9/15/23  
To amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes.

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4468

Introduced
7/6/23  
Refer
7/6/23  
Refer
7/7/23  
Report Pass
7/27/23  
Choice in Automobile Retail Sales Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4469

Introduced
7/6/23  
Refer
7/6/23  
Refer
7/7/23  
No Fuel Credits for Batteries Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4531

Introduced
7/11/23  
Refer
7/11/23  
Report Pass
7/19/23  
Report Pass
9/28/23  
Support for Patients and Communities Reauthorization Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4563

Introduced
7/11/23  
Refer
7/11/23  
Refer
7/11/23  
ACE Act End Zuckerbucks Act of 2023 Solving an Overlooked Loophole in Votes for Executives (SOLVE) Act Promoting Free and Fair Elections Act Don't Weaponize the IRS Act American Confidence in Elections Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4581

Introduced
7/12/23  
Refer
7/12/23  
Refer
7/14/23  
Report Pass
3/20/24  
Engrossed
5/16/24  
Enrolled
7/8/24  
Passed
7/12/24  
Chaptered
7/12/24  
Maternal and Child Health Stillbirth Prevention Act of 2024
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4721

Introduced
7/18/23  
Main Street Tax Certainty Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB497

Introduced
1/25/23  
Refer
1/25/23  
Engrossed
2/1/23  
Freedom for Health Care Workers Act This bill nullifies the rule titled Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination, which was issued by the Centers for Medicare & Medicaid Services on November 5, 2021, and prohibits the issuance of any substantially similar rule. The rule requires health care providers, as a condition of Medicare and Medicaid participation, to ensure that staff are fully vaccinated against COVID-19.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB5371

Introduced
9/8/23  
Refer
9/8/23  
Refer
9/15/23  
Choices for Increased Mobility Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB5400

Introduced
9/12/23  
Refer
9/12/23  
NO PBMs Act Neighborhood Options for Patients Buying Medicines Act